Imavita
No Reviews Yet
No Completed Orders
Ramonville Saint Agne, FR
Imavita is an innovating technology company proposing preclinical services in the exploration of preclinical models of human pathologies by the use of innovating imaging techniques. The vision of our company is to propose to pharmaceutical industries, biotechnology companies and other private &... Show more »
Imavita is an innovating technology company proposing preclinical services in the exploration of preclinical models of human pathologies by the use of innovating imaging techniques. The vision of our company is to propose to pharmaceutical industries, biotechnology companies and other private & public laboratories, innovating solutions in efficacy / toxicity evaluation of active ingredients in laboratory species by the use of non invasive imaging techniques and appropriate imaging analysis for quantitative evaluation of specific imaging biomarkers. Imavita is actually developing the following tools:
- Pre-clinical testing in laboratory species (induction of pathologies / treatment & sampling phases)
- Imaging techniques like SPECT/CT, CT with Single/Dual Energy CT approach, MRI, ultrasonography, etc…
- Images exploitation and analysis for quantitative imaging
Imavita focus its activities in the following domains:
- Cardiovascular diseases
- Osteo-articular pathologies
- Dermatology
- Oncology
- Neurology
- Drug disposition / PK
- Medical Devices
Imavita is member of AFSSI (“Association Française des Sociétés de Services et d’Innovation pour les Sciences de la Vie” / French association of innovating services companies in life sciences)
Imavita proposes preclinical models which can be used alone or associated with imaging modalities to permit the evaluation of efficacy of new compounds / new therapeutics treatments in development phase.
Species / strains
Imavita proposes preclinical models which can be used alone or associated with imaging modalities to permit the evaluation of efficacy of new compounds / new therapeutics treatments in development phase.
Species / strains
Type of studies
Example of projects
Type of studies
Example of projects
Resources
Imavita proposes preclinical models which can be used alone or associated with imaging modalities to permit the evaluation of efficacy of new compounds / new therapeutics treatments in development phase.
Species / strains
Imavita proposes preclinical models which can be used alone or associated with imaging modalities to permit the evaluation of efficacy of new compounds / new therapeutics treatments in development phase.
Species / strains
Type of studies
Example of projects
Type of studies
Example of projects
Resources
Imavita has not received any reviews.
Imavita has not received any endorsements.